Investigative Site US239 — Omaha, Nebraska

Investigative Site US239 is a clinical research site located in Omaha, Nebraska, United States 68144.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Investigative Site US239 has participated in 1 clinical trials.

Therapeutic areas: Hidradenitis Suppurativa (HS).

Sponsors: Incyte Corporation.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigative Site US239?

Investigative Site US239 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigative Site US239 conducted?

Investigative Site US239 has 1 clinical trials on record. Their work covers Hidradenitis Suppurativa (HS).

Is Investigative Site US239 accredited by Crixeo Health?

Investigative Site US239 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigative Site US239?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.